Reports
-
From the ground up: Building a drug-resistant TB programme in Uganda
Uganda is one of the world's 22 high burden countries for tuberculosis (TB). Despite having a national treatment programme for drug-sensitive TB, there has been an emergence of drug-resistant strains of the disease, which are presenting a new and urgent threat to people's health. So far in Uganda, 226 cases of multidrug-resistant tuberculosis (MDR-TB) have been confirmed, spread across 40 districts, but the true figure is likely to be much higher.
Last updated 23 April 2012
www.msfaccess.org/content/ground-building-drug-resistant-tb-programme-uganda -
The Right Shot: Extending the reach of affordable and adapted vaccines
Last updated 10 April 2012
www.msfaccess.org/content/rightshot -
Antiretroviral Sequencing Meeting Report
MSF, Solidarité thérapeutique hospitalière en réseau (Esther), Solidarité thérapeutique contre le sida (SOLTHIS) convened a meeting in September 2011 of HIV treatment experts to look at antiretroviral regimens and strategies to support the further scale up treatment and long-term sustainability in resource-limited settings. The meeting objectives were to:
Last updated 21 March 2012
www.msfaccess.org/content/antiretroviral-sequencing-meeting-report -
Lives in the balance: The urgent need for HIV and TB treatment in Myanmar
The UN estimates that over the last few years between 15,000 - 20,000 people living with HIV die annually in Myanmar, because of lack of access to urgent lifesaving anti-retroviral therapy (ART).
Last updated 22 February 2012
www.msfaccess.org/content/lives-balance-urgent-need-hiv-and-tb-treatment-myanmar -
Ten Stories that Mattered in Access to Medicines in 2011
Last updated 20 December 2011
www.msfaccess.org/10stories2011 -
10 Years of Antiretrovirals: Treatment in Malawi by MSF
A special report created for World AIDS Day 2011 that gives an overview of MSF's 10 years of work to provide treatment for HIV+ people in Malawi. The report includes patient testimonies, a timeline of MSF's work in Malawi, a special report on the prevention of mother-to-child transmission (PMTCT) and, importantl, the challenges that lie ahead.
Last updated 29 November 2011
www.msfaccess.org/content/10-years-antiretrovirals-treatment-malawi-msf -
Meeting Report: Saving more lives with artesunate injection
On 11 November 2011, the Medicines for Malaria Venture (MMV), World Health Organization (WHO) and Médecins Sans Frontières (MSF), brought together organisations from across the field of malaria to identify obstacles in adopting new severe malaria treatment guidelines and define a way forward. » DOWNLOAD a copy of “Saving more lives with artesunate injection”, the official meeting report
Last updated 11 November 2011
www.msfaccess.org/content/meeting-report-saving-more-lives-artesunate-injection -
Out of the Dark: Meeting the Needs of Children With TB
This report will outline the current state of paediatric TB care, looking at current practices, new developments and research needs – in paediatric TB diagnosis, treatment and prevention. It intends to act as a guide to treatment programmes for implementation of the best standard of care currently available to children with TB, and to raise awareness of the need to continue to push for improvements in the management of childhood TB.
Last updated 26 October 2011
www.msfaccess.org/content/out-dark-meeting-needs-of-children-with-TB -
Five Lives: How a Financial Transaction Tax Could Support Global Health
‘5 Lives’ are the stories of people that MSF works with every day, whose health and lives often hang on a simple medical intervention. These personal experiences are a snapshot of the unnecessary suffering MSF medical staff see first-hand daily in places where people can’t get adequate medical care and that could be avoided with proper, sustainable funding and investment.
Last updated 20 October 2011
www.msfaccess.org/content/five-lives-how-financial-transaction-tax-could-support-global-health -
Towards Lab-Free Tuberculosis Diagnosis
Tuberculosis (TB), fuelled in part by the HIV epidemic, remains a major challenge to public health. Despite the potential for most cases of tuberculosis to be curable, TB causes around two million deaths per annum. These deaths are in part due to late or missed diagnosis. Improving the performance of diagnostics and their availability are key to reducing global morbidity and mortality.
Last updated 22 August 2011
www.msfaccess.org/content/towards-lab-free-tuberculosis-diagnosis
